High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients

PHASE2RecruitingINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

November 8, 2022

Primary Completion Date

July 31, 2027

Study Completion Date

December 31, 2027

Conditions
Immunization; InfectionTransplantation InfectionInfluenza
Interventions
BIOLOGICAL

High Dose Quadrivalent Inactivated Influenza Vaccine

"Fluzone High-Dose (Influenza Vaccine) for intramuscular injection is an inactivated influenza vaccine, prepared from influenza viruses propagated in embryonated chicken eggs. The virus-containing allantoic fluid is harvested and inactivated with formaldehyde. Influenza virus is concentrated and purified in a linear sucrose density gradient solution using a continuous flow centrifuge. The virus is then chemically disrupted using a non-ionic surfactant, octylphenol ethoxylate (Triton® X-100), producing a split virus. The split virus is further purified and then suspended in sodium phosphatebuffered isotonic sodium chloride solution. The Fluzone High-Dose process uses an additional concentration factor after the ultrafiltration step in order to obtain a higher hemagglutinin (HA) antigen concentration."

BIOLOGICAL

Standard Dose Quadrivalent Inactivated Influenza Vaccine

Fluzone ® Quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by two influenza A subtype viruses and two type B viruses contained in the vaccine.

Trial Locations (1)

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Northwestern University Feinberg School of Medicine

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

Duke University

OTHER

collaborator

University of Washington

OTHER

collaborator

Emory University

OTHER

collaborator

Baylor College of Medicine

OTHER

collaborator

NYU Langone Health

OTHER

lead

Vanderbilt University Medical Center

OTHER

NCT05215327 - High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients | Biotech Hunter | Biotech Hunter